Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancer
US12145925B2 · kind B2 · utility
0Cited by
4References
33Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 15, 2021 |
| Grant date | Nov 19, 2024 |
| Priority date | — |
| Expiry date | May 31, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The application relates to phthalazine derivatives of formula (I) which are inhibitors of PARP1, PARP2 and/or tubulin and thus useful for the treatment of cancer. Also disclosed are pharmaceutical formulations containing such compounds, as well as combinations of these compounds with at least one additional therapeutic agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.